Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials

Published:2016-07-25 Issue:8 Volume:70 Page:649-656
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Xue X.¹,Ren Z.¹,Zhang A.²,Yang Q.³,Zhang W.⁴,Liu F.¹⁴

Affiliation:

1. Department of Endocrinology; Tengzhou Central People's Hospital; Shandong China

2. Zaozhuang Science and Technology College; Shandong China

3. Department of Medicine; Maternal and Child Care Service Centre of Tengzhou City; Shandong China

4. Division of Endocrinology and Diabetology; Department of Internal Medicine II; University Hospital of Freiburg; Freiburg Germany

Publisher

Hindawi Limited

Subject

General Medicine

Reference35 articles.

1. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);United Kingdom Prospective Diabetes Study (UKPDS) Group;Lancet,1998

2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000

3. Hyperglycemia and microvascular and macrovascular disease in diabetes;Klein;Diabetes Care,1995

4. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes;Morrish;Diabetologia,2001

5. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition;Klein;Diabetes Care,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence;Physiology & Behavior;2024-07

2. Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity;Obesity Facts;2022-11-08

3. EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 ON THE PANCREAS OF OLETF RATS;ACTA MEDICA MEDITERR;2022

4. The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism;Expert Opinion on Drug Safety;2021-08-25

5. Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway;Chinese Medical Journal;2021-01-19